Accessibility Menu
Akso Health Group logo

Akso Health Group(NASDAQ) HX

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-98%
5 Year-54%
1 Year-51%
1 Month-41%
N/A
Akso Health Group last closing stock price
MetricPriceDate
Last closeUSD 0.862026-08-28
Akso Health Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-7.84%USD 0.932026-08-21
1 month-41.32%USD 1.462026-07-29
3 month-43.63%USD 1.522026-05-29
Year to date-47.76%USD 1.642025-12-31
1 year-50.76%USD 1.742025-08-28
3 year+17.37%USD 0.732023-08-29
5 year-54.43%USD 1.882021-08-27
Since inception-97.65%USD 36.422017-11-03

Akso Health Group Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$21.57M

Net Income (TTM)

-$100.55M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Dec 16, 2021

HX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Akso Health Group

Akso Health Group operates a social e-commerce mobile platform in China, focusing on diverse product offerings including food, beverages, cosmetics, and medical devices. The company aims to enhance consumer access to health-related products and services through innovative technology.

Products and Services
  • Xiaobai Maimai App for social e-commerce
  • Medical devices like defibrillators and anesthesia laryngoscopes
  • Health treatment and consultancy services
Growth Outlook
  • Expansion in the Chinese e-commerce market projected to grow significantly
  • Increased demand for health-related products amid rising health awareness
  • Strategic partnerships expected to enhance product offerings and market reach
Financial Highlights
  • Recent quarterly revenue of $3.42 million, showing resilience
  • Trailing twelve months (TTM) revenue of $13.5 million
  • Current ratio of 21.77 indicates strong liquidity position
Akso Health Group is positioned in a rapidly growing sector, leveraging technology to meet consumer needs. The company's diverse product range and focus on health-related services align with market trends favoring e-commerce and health awareness. Recent financial performance, including a solid current ratio, reflects a strong liquidity position, which may appeal to potential investors. The growth outlook remains positive, driven by market expansion and increasing consumer demand for health products.
AI Generated • Aug 20, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

12

CEO

Yi Lin Wang

Website

www.ahgtop.com

Headquarters

Beijing, 100020, CN

HX Financials

Key Financial Metrics (TTM)

Gross Margin

-3.93%

Operating Margin

-721.63%

Net Income Margin

-667.88%

Return on Equity

-50.15%

Return on Capital

-99.55%

Return on Assets

-50.20%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$15.13M

Operating Income

-$94.26M

EBITDA

-$90.95M

Operating Cash Flow

$75.30M

Capital Expenditure

-$400.00K

Free Cash Flow

$74.90M

Cash & ST Invst.

$15.46M

Total Debt

$10.00M

Akso Health Group Performance Analysis

Akso Health Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31USD 13,133,879118.4%
20242024-03-31USD 2,409,943-81.7%
20252025-03-31USD 14,795,295513.9%
20262026-03-31USD 13,880,402-6.2%
Akso Health Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42020-03-31N/A
Q22020-09-30N/A
Q42021-03-31N/A
Q22021-09-30N/A
Akso Health Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31USD -0.06-93.0%
20242024-03-31USD -0.19224.0%
20252025-03-31USD -0.47147.1%
20262026-03-31USD -0.03-94.5%
Akso Health Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42020-03-31N/A
Q22020-09-30N/A
Q42021-03-31N/A
Q22021-09-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2021YOY CHG

Revenue

$676.61K

-83.7%

Gross Profit

-$5.76M

-239.0%

Gross Margin

-8.52%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

113

N/A

Net Income

-$11.79M

-514.2%

EBITDA

-$9.30M

-297.7%

Quarterly Fundamentals

Name
Q2 2021YOY CHG

Total Cash

$15.46M

+3.4%

Total Debt

$10.00M

-56.2%

Accounts Receivable

$6.56M

-66.9%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$10.00M

+250.4%

Return on Assets

-50.20%

N/A

Return on Invested Capital

-56.85%

N/A

Free Cash Flow

$0.00

-100.0%

Operating Cash Flow

$0.00

-100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EAREargo, Inc.
$2.57-4.10%
KRONKronos Bio, Inc.
$0.88+1.49%
SGTXSigilon Therapeutics, Inc.
$22.47-2.56%
OMICSingular Genomics Systems, Inc.
$20.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About HX

What is the current price of Akso Health Group?

Akso Health Group is trading at N/A per share.

What is the 52-week range for Akso Health Group?

Over the past 52 weeks, Akso Health Group has traded between N/A and N/A.

How much debt does Akso Health Group have?

As of the most recent reporting period, Akso Health Group reported total debt of $2.38M.

How much cash does Akso Health Group have on hand?

Akso Health Group reported $170.58K in cash and cash equivalents in its most recent financial results.

What is Akso Health Group’s dividend yield?

Akso Health Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services